Phase Ib/II study of biweekly TAS-102 with bevacizumab combination for patients with metastatic colorectal cancer refractory to standard therapies (BiTS study): Phase Ib results

Y. Kagawa, H. Satake, T. Kato, K. Oba, H. Yasui, M. Nakamura, T. Watanabe, K. Hirata, K. Muro, Y. Komatsu, T. Yoshino, K. Yamazaki, H. Mishima, M. Kotaka, A. Tsuji, Y. Kakeji, E. Oki, N. Nagata, S. Junichi

Research output: Contribution to journalArticlepeer-review

Original languageEnglish
Pages (from-to)ix34-ix35
JournalAnnals of oncology : official journal of the European Society for Medical Oncology
Publication statusPublished - Nov 1 2018

All Science Journal Classification (ASJC) codes

  • Hematology
  • Oncology

Cite this